Product Information
CLONIDINE HCL 0.3 MG TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.0408 per EA under NDC 58657064901. Its NADAC has been published 299 times since Jan 13, 2021.
FDA first approved this application on Jun 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657064901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLONIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202297FDA Approved
6/13/2013
TE Code
AB
On Market Since
7/1/2020
Pharmacological Classes
Price Statistics
The NADAC for CLONIDINE HCL 0.3 MG TABLET has been published 299 times since Jan 13, 2021, and over the history we have for it it has declined 19.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0408 per EA |
|---|---|
| All-time high | $0.0505 (Apr 14, 2021) |
| All-time low | $0.0321 (Nov 20, 2024) |
| 52-week high | $0.0412 |
| 52-week low | $0.0388 |
| Median price | $0.0404 |
| Average price | $0.0406 |
| Largest weekly change | +25.5% (Aug 21, 2024) |
| Weeks tracked | 299 |
| Tracking since | Jan 13, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clonidine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLONIDINE HCL 0.3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONIDINE HCL 0.3 MG TABLET, manufactured by Method Pharmaceuticals LLC, is $0.0408 per EA (NDC 58657064901), effective Sep 30, 2026.
How has the price of CLONIDINE HCL 0.3 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONIDINE HCL 0.3 MG TABLET has declined 19.1%. It has been tracked across 299 weekly CMS publications since Jan 13, 2021.
What are the highest and lowest recorded NADAC prices for CLONIDINE HCL 0.3 MG TABLET?
Since Jan 13, 2021, the NADAC for CLONIDINE HCL 0.3 MG TABLET has ranged from a low of $0.0321 (Nov 20, 2024) to a high of $0.0505 (Apr 14, 2021), with a median of $0.0404 per EA.
Are there cheaper alternatives to CLONIDINE HCL 0.3 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLONIDINE HCL 0.3 MG TABLET, is $0.0401 per EA — about 2% below CLONIDINE HCL 0.3 MG TABLET.
Who manufactures CLONIDINE HCL 0.3 MG TABLET?
CLONIDINE HCL 0.3 MG TABLET (NDC 58657064901) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.